Effect of Functional Magnetic Therapy on Constipation Predominant- Irritable Bowel Syndrome (IBS-C)

NCT07256262 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-12-01

No results posted yet for this study

Summary

The aim of this study is to evaluate the potential benefits of functional magnetic therapy on constipation improvement and related symptoms in patients with IBS-C, including abdominal pain, bloating, bowel habits, and quality of life, as well as to assess patient satisfaction and experience with the therapy.

Conditions

  • Irritable Bowel Syndrome

Interventions

DEVICE

Functional magnetic stimulation (FMS)

Every patient will receive 20-minute FMS sessions on the TESLA FORMER device. Each treatment session will consist of one cycle (20 minutes each) based on the treatment area's size and the investigator's discretion. Treatment will be administered by a single applicator secured directly over the abdominal muscles. The device's output intensity will be escalated to a tolerable level depending on patient feedback, with average maximum intensities ranging from 98% to 100% across treatment sessions. The treatment will be 20 minutes long, with several steps including different frequency modulations to achieve stimulation of different muscle fibres.

DRUG

Conventional pharmacological therapy

Every patient in both groups will receive conventional pharmacological therapy for 8 weeks.

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Tamer I Abo Elyazed, PhD · Assistant Professor, Beni-Suef University

  • Ragaey Ahmad Eid, PhD · Assistant Professor, Beni-Suef University

  • Marwa Mohamed Eleawa · Lecturer, Beni-Suef University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-28
Primary Completion
2026-01-28
Completion
2026-02-14

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07256262 on ClinicalTrials.gov